- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04119141
Benefit of Tin Filter in Regards to Image Quality and Radiation Dose in CT Scan Study of Pulmonary Parenchyma
Benefit of Tin Filter in Regards to Image Quality and Radiation Dose in CT Scan
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The chest x-ray is the first-line exam for the study of pulmonary parenchyma. Nevertheless, it does not make it possible to reveal all pulmonary pathologies, and in particular those of very small sizes. Thanks to its very high spatial resolution and contrast resolution, the scanner is able to detect all infra-millimetric pathologies of the pulmonary parenchyma but also mediastinal pathologies that could not have been seen on the standard x-ray.
This study fits into the context of pleural pathology screening for patients exposed to asbestos in their professional environment.
Today, the chest CT scan in millimetric sections isth e standardised method used in the context of this screening.Tin filtration is an additional filtration at the output of the X-ray tube made available on premium Siemens scanners. In diagnostic medical imaging, the photon beam has an energetic spectrum ranging from 0 to 150 keV. However the weak energies do not participate in the formation of the image but, on the other hand, to the overall radiation of the patient. The purpose of the addition of the tin filter is to be able to suppress, at the output of the tube, all low and medium energy levels, only allowing high energy levels to pass through. A previous study comparing the same group of patients on two different machines (one with tin filtration, one without tin filtration) showed a significant decrease in the radiation dose; nevertheless, a certain number of parameters differed between the two scanners used. In order to get rid of the different biases encountered on previous published studies, we propose to carry out this study on the same machine, by activating and deactivating tin filtration, all other parameters of acquisition and reconstruction of the image being equal in all respects.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
IDF
-
Antony, IDF, France, 92160
- Recruiting
- Hôpital Privé d'Antony Antony
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient aged 18 and over.
- Patient referred for chest CT scan in the context of screening or monitoring of occupational exposure to asbestos.
- Patient with health insurance or beneficiary of a social security scheme.
- Patient having given their express consent.
Exclusion Criteria:
- Woman who is pregnant or likely to be pregnant.
- Lactating or parturient women
- Minors.
- Protected patients: Adults under trusteeship, guardianship or other legal protection, deprived of liberty by judicial or administrative decision; hospitalised without consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Arm
the first acquisition will be carried out without a tin filter in supine position and the second with tin filter in procubitus.
|
Acquisition:
Reconstruction:
|
Experimental: Tin filter Arm
the first acquisition will be carried out with tin filter in supine position and the second without tin filter in procubitus.
|
Acquisition:
Reconstruction:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Likert score scale score
Time Frame: 1 hour
|
Primary endpoint: score obtained on the Likert scale.
|
1 hour
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2018-A00918-47
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tin X Ray
-
Markus KnuppMerian Iselin Klinik; Basel Academy for Quality and Research in MedicineRecruiting
-
GE HealthcareCompleted
-
Yonsei UniversityCompletedChest X-ray for Clinical EvaluationKorea, Republic of
-
HaEmek Medical Center, IsraelCompletedX-ray Contrast Media Adverse ReactionIsrael
-
Reto Sutter, MDNot yet recruitingDiagnostic Imaging | Tomography, X Ray Computed
-
The University of Texas Health Science Center,...Samsung ElectronicsCompletedChest X-ray for Clinical EvaluationUnited States
-
University Hospital, BrestCompletedMeasure of the X-ray DoseFrance
-
Alko Do Brasil Industria e Comercio LtdaUnknownX-ray Examinations of the Gastrointestinal Tract
-
Tommaso GoriCompletedExposure of Member of Staff to Medical Diagnostic X-RayGermany
-
BayerCompleted
Clinical Trials on X ray imaging
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
National Cancer Institute (NCI)Active, not recruiting
-
Sheffield Children's NHS Foundation TrustCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingMelanoma | Neuroblastoma | Pancreatic Ductal Adenocarcinoma | Refractory Malignant Solid Neoplasm | Endometrial Carcinoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Non-Hodgkin Lymphoma | Recurrent Osteosarcoma | Refractory Ewing Sarcoma | Refractory... and other conditionsUnited States
-
Ottawa Hospital Research InstituteUnknownSpinal Fusion | Total Hip ReplacementCanada
-
University of California, San FranciscoPfizerCompletedOsteoarthritisUnited States
-
The University of Texas Health Science Center,...Samsung ElectronicsCompleted
-
Sunnybrook Health Sciences CentreGeneral ElectricUnknownCardiovascular DiseasesCanada
-
Assiut UniversityWithdrawn
-
Central South UniversityCompletedOsteoporosis FractureChina